Searchable abstracts of presentations at key conferences in endocrinology

ea0032s6.1 | What's new in type 2 diabetes? | ECE2013

The impact of our genomes on metabolic health

Hansen Torben

For the past two decades, genetics has been widely explored as a tool for unravelling the pathogenesis of cardio-metabolic disorders. Many risk alleles for type 2 diabetes and hyperglycaemia have been detected in recent years through massive genome-wide association studies and evidence exists that most of these variants influence pancreatic β-cell function. Investigations of more detailed physiological phenotypes, are now emerging and give indications of more specific pat...